PwC report: Building FDA, consumer relationships critical to life sciences industry growth

Bringing novel – and cost-effective – new drugs and devices to the market is the lifeblood of the life sciences industry, but it can’t do it without a symbiotic relationship with patients and regulators. PricewaterhouseCoopers just put out a new report that highlights the relationship between the Food and Drug Administration, the life sciences industry and consumers. Here’s what […]

The economics of high-cost specialty drugs, illustrated

Specialty drugs – the costly medications used to treat complex disease like cancer and Hepatitis C – have become a hot-button topic given the fact that healthcare spending is perpetually on the rise. After a five-year contraction in healthcare spending growth, medical costs are projected to climb another 6.8 percent in 2015, according to the Health […]